Type(s) of immunotherapy-Yervoy (Ipilimumab) Posts on Medivizor
Navigation Menu

Type(s) of immunotherapy-Yervoy (Ipilimumab) Posts on Medivizor

Influenza vaccination and immune-checkpoint inhibitors – what are the risks to patients with cancer?

Posted by on Mar 31, 2019 in Melanoma | 0 comments

In a nutshell This study investigated the effect of immune-checkpoint inhibitors (ICIs) on influenza vaccination in patients with cancer. They found that influenza vaccination is safe in these patients Some background Immune-checkpoint inhibitors (ICIs) are a new type of drug to treat cancer. ICIs can be effective in some advanced cancers,...

Read More

Does body-mass index (BMI) affect survival in patients with metastatic melanoma?

Posted by on Jul 3, 2018 in Melanoma | 0 comments

In a nutshell This study investigated whether body-mass index (BMI) had any effect on survival in patients with metastatic melanoma who received targeted therapy, immunotherapy, or chemotherapy. The study found that male metastatic melanoma patients who had a high BMI had improved survival compared to patients with normal BMI. Some background Targeted...

Read More

Guidelines for treatment of ipilimumab-associated hypophysitis in advanced melanoma

Posted by on Nov 21, 2016 in Melanoma | 0 comments

In a nutshell This study developed guidelines for the early detection and treatment of hypophysitis (HP; inflammation of the pituitary gland), a side effect of treatment with ipilimumab. Researchers suggested that these guidelines are necessary to ensure early detection and treatment of this condition to prevent associated mortality. Some background...

Read More

Treatment options for eye melanoma: a review

Posted by on Jul 26, 2015 in Melanoma | 0 comments

In a nutshell The authors reviewed the biology as well as current and future treatment options for eye melanoma.  Some background Uveal melanoma is a rare cancer (melanoma) of the eye. It involves three parts of the eye (iris, ciliary body and choroid) known together as the uvea. Eye melanoma is associated with a high risk...

Read More